• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

WNT5A 通过 SRC/ERK/MMP-14 通路促进人骨肉瘤细胞的迁移和侵袭。

WNT5A promotes migration and invasion of human osteosarcoma cells via SRC/ERK/MMP-14 pathway.

机构信息

Department of Orthopaedics, Second Hospital of Lanzhou University, Lanzhou, 730000, China.

Orthopaedics Key Laboratory of Gansu Province, Lanzhou, 730000, China.

出版信息

Cell Biol Int. 2018 May;42(5):598-607. doi: 10.1002/cbin.10936. Epub 2018 Feb 6.

DOI:10.1002/cbin.10936
PMID:29345412
Abstract

WNT5A, a representative ligand of activating several non-canonical WNT signal pathways, plays significant roles in oncogenesis and tumor inhibition. It has been shown that the non-receptor tyrosine kinase SRC is required for WNT5A-induced invasion of osteosarcoma cells. However, the precise molecular mechanism underlying WNT5A/SRC-mediated osteosarcoma cells invasion remains poorly defined. The study was designed to explore the role of ERK1/2 in WNT5A/SRC-induced osteosarcoma cells invasion and the downstream target of the SRC/ERK1/2 signalings. We found that WNT5A (100 ng/mL) remarkably stimulated migration and invasion of human osteosarcoma MG-63 cells, whereas inhibiting either SRC kinase activity by siRNA-mediated SRC silence or ERK1/2 phosphorylation by PD98059 treatment suppressed these effects, which suggested that the activation of SRC and ERK1/2 is essential for WNT5A-induced MG-63 cells migration and invasion. Furthermore, ERK1/2 phosphorylation induced by WNT5A was dramatically blocked by SRC siRNA. Additionally, our study further demonstrated that MMP-14 was upregulated after exposure to WNT5A in MG-63 cells, and the increased expression was blocked by SRC siRNA or PD98059. Collectively, these results indicate that WNT5A activates SRC/ERK1/2 signal pathway, leading to the upregulation of MMP-14 expression and MG-63 cells migration and invasion.

摘要

WNT5A 是几种非经典 WNT 信号通路的代表性配体,在肿瘤发生和肿瘤抑制中发挥重要作用。已经表明,非受体酪氨酸激酶 SRC 是 WNT5A 诱导骨肉瘤细胞侵袭所必需的。然而,WNT5A/SRC 介导的骨肉瘤细胞侵袭的确切分子机制仍不清楚。本研究旨在探讨 ERK1/2 在 WNT5A/SRC 诱导的骨肉瘤细胞侵袭中的作用以及 SRC/ERK1/2 信号转导的下游靶标。我们发现,WNT5A(100ng/mL)显著刺激人骨肉瘤 MG-63 细胞的迁移和侵袭,而通过 siRNA 介导的 SRC 沉默抑制 SRC 激酶活性或通过 PD98059 处理抑制 ERK1/2 磷酸化则抑制了这些作用,这表明 SRC 和 ERK1/2 的激活对于 WNT5A 诱导的 MG-63 细胞迁移和侵袭是必需的。此外,WNT5A 诱导的 ERK1/2 磷酸化被 SRC siRNA 显著阻断。此外,我们的研究进一步表明,WNT5A 暴露于 MG-63 细胞后 MMP-14 的表达上调,并且 SRC siRNA 或 PD98059 阻断了这种上调。总之,这些结果表明,WNT5A 激活 SRC/ERK1/2 信号通路,导致 MMP-14 表达上调以及 MG-63 细胞迁移和侵袭。

相似文献

1
WNT5A promotes migration and invasion of human osteosarcoma cells via SRC/ERK/MMP-14 pathway.WNT5A 通过 SRC/ERK/MMP-14 通路促进人骨肉瘤细胞的迁移和侵袭。
Cell Biol Int. 2018 May;42(5):598-607. doi: 10.1002/cbin.10936. Epub 2018 Feb 6.
2
Autonomous regulation of osteosarcoma cell invasiveness by Wnt5a/Ror2 signaling.Wnt5a/Ror2信号通路对骨肉瘤细胞侵袭的自主调节
Oncogene. 2009 Sep 10;28(36):3197-208. doi: 10.1038/onc.2009.175. Epub 2009 Jun 29.
3
Bufalin-inhibited migration and invasion in human osteosarcoma U-2 OS cells is carried out by suppression of the matrix metalloproteinase-2, ERK, and JNK signaling pathways.蟾毒灵通过抑制基质金属蛋白酶-2、ERK 和 JNK 信号通路抑制人骨肉瘤 U-2 OS 细胞的迁移和侵袭。
Environ Toxicol. 2014 Jan;29(1):21-9. doi: 10.1002/tox.20769. Epub 2011 Sep 16.
4
Geraniin inhibits migration and invasion of human osteosarcoma cancer cells through regulation of PI3K/Akt and ERK1/2 signaling pathways.香叶木素通过调节PI3K/Akt和ERK1/2信号通路抑制人骨肉瘤癌细胞的迁移和侵袭。
Anticancer Drugs. 2017 Oct;28(9):959-966. doi: 10.1097/CAD.0000000000000535.
5
Astrocyte elevated gene-1 (AEG-1) promotes osteosarcoma cell invasion through the JNK/c-Jun/MMP-2 pathway.星形细胞上调基因-1(AEG-1)通过 JNK/c-Jun/MMP-2 通路促进骨肉瘤细胞侵袭。
Biochem Biophys Res Commun. 2014 Oct 3;452(4):933-9. doi: 10.1016/j.bbrc.2014.09.009. Epub 2014 Sep 6.
6
Proline-rich tyrosine kinase 2 (Pyk2) promotes proliferation and invasiveness of hepatocellular carcinoma cells through c-Src/ERK activation.富含脯氨酸的酪氨酸激酶2(Pyk2)通过激活c-Src/ERK促进肝癌细胞的增殖和侵袭。
Carcinogenesis. 2008 Nov;29(11):2096-105. doi: 10.1093/carcin/bgn203. Epub 2008 Sep 1.
7
Effects of FOSL1 silencing on osteosarcoma cell proliferation, invasion and migration through the ERK/AP-1 signaling pathway.沉默 FOSL1 通过 ERK/AP-1 信号通路对骨肉瘤细胞增殖、侵袭和迁移的影响。
J Cell Physiol. 2019 Apr;234(4):3598-3612. doi: 10.1002/jcp.27048. Epub 2018 Nov 23.
8
3-Hydroxyflavone inhibits human osteosarcoma U2OS and 143B cells metastasis by affecting EMT and repressing u-PA/MMP-2 via FAK-Src to MEK/ERK and RhoA/MLC2 pathways and reduces 143B tumor growth in vivo.3-羟基黄酮通过影响上皮-间质转化(EMT)并经由黏着斑激酶(FAK)-Src至丝裂原活化蛋白激酶/细胞外信号调节激酶(MEK/ERK)和RhoA/肌球蛋白轻链2(MLC2)途径抑制尿激酶型纤溶酶原激活剂(u-PA)/基质金属蛋白酶-2(MMP-2),从而抑制人骨肉瘤U2OS和143B细胞转移,并在体内减少143B肿瘤生长。
Food Chem Toxicol. 2016 Nov;97:177-186. doi: 10.1016/j.fct.2016.09.006. Epub 2016 Sep 4.
9
Zoledronate blocks geranylgeranylation not farnesylation to suppress human osteosarcoma U2OS cells metastasis by EMT via Rho A activation and FAK-inhibited JNK and p38 pathways.唑来膦酸通过激活Rho A以及抑制FAK-JNK和p38通路,阻断香叶基香叶基化而非法尼基化,从而通过上皮-间质转化抑制人骨肉瘤U2OS细胞转移。
Oncotarget. 2016 Mar 1;7(9):9742-58. doi: 10.18632/oncotarget.7138.
10
Notch signaling regulates osteosarcoma proliferation and migration through Erk phosphorylation.Notch 信号通路通过 Erk 磷酸化调节骨肉瘤的增殖和迁移。
Tissue Cell. 2019 Aug;59:51-61. doi: 10.1016/j.tice.2019.07.002. Epub 2019 Jul 2.

引用本文的文献

1
Flavokawain A suppresses the malignant progression of neuroblastoma in vitro depending on inactivation of ERK/VEGF/MMPs signaling pathway.黄樟素A通过使ERK/VEGF/MMPs信号通路失活,在体外抑制神经母细胞瘤的恶性进展。
Discov Oncol. 2024 Nov 19;15(1):677. doi: 10.1007/s12672-024-01568-y.
2
Bone sialoprotein facilitates anoikis resistance in lung cancer by inhibiting miR-150-5p expression.骨涎蛋白通过抑制 miR-150-5p 的表达促进肺癌的抗失巢凋亡。
J Cell Mol Med. 2024 Oct;28(20):e70155. doi: 10.1111/jcmm.70155.
3
Effect of traditional Chinese medicine in osteosarcoma: Cross-interference of signaling pathways and potential therapeutic targets.
中药在骨肉瘤中的作用:信号通路的交叉干扰和潜在的治疗靶点。
Medicine (Baltimore). 2024 Jan 19;103(3):e36467. doi: 10.1097/MD.0000000000036467.
4
Isorhamnetin Downregulates MMP2 and MMP9 to Inhibit Development of Rheumatoid Arthritis through SRC/ERK/CREB Pathway.山奈酚通过 SRC/ERK/CREB 通路下调 MMP2 和 MMP9 抑制类风湿关节炎的发展。
Chin J Integr Med. 2024 Apr;30(4):299-310. doi: 10.1007/s11655-023-3753-6. Epub 2024 Jan 12.
5
Exploration in the Mechanism of Ginsenoside Rg5 for the Treatment of Osteosarcoma by Network Pharmacology and Molecular Docking.网络药理学和分子对接探究人参皂苷 Rg5 治疗骨肉瘤的作用机制。
Orthop Surg. 2024 Feb;16(2):462-470. doi: 10.1111/os.13971. Epub 2023 Dec 12.
6
Aberrant expression of UBE2C in endometrial cancer and its correlation to epithelial mesenchymal transition.UBE2C 在子宫内膜癌中的异常表达及其与上皮间质转化的关系。
Medicine (Baltimore). 2023 May 19;102(20):e33834. doi: 10.1097/MD.0000000000033834.
7
Non-canonical WNT5A-ROR signaling: New perspectives on an ancient developmental pathway.非经典 WNT5A-ROR 信号通路:古老发育途径的新视角。
Curr Top Dev Biol. 2023;153:195-227. doi: 10.1016/bs.ctdb.2023.01.009. Epub 2023 Mar 17.
8
PROSER2 is a poor prognostic biomarker for patients with osteosarcoma and promotes proliferation, migration and invasion of osteosarcoma cells.PROSER2是骨肉瘤患者预后不良的生物标志物,可促进骨肉瘤细胞的增殖、迁移和侵袭。
Exp Ther Med. 2022 Nov 8;24(6):750. doi: 10.3892/etm.2022.11686. eCollection 2022 Dec.
9
Chemoresistance-Related Stem Cell Signaling in Osteosarcoma and Its Plausible Contribution to Poor Therapeutic Response: A Discussion That Still Matters.骨肉瘤中与化疗耐药相关的干细胞信号及其对治疗反应不良的可能贡献:一个仍有意义的讨论。
Int J Mol Sci. 2022 Sep 27;23(19):11416. doi: 10.3390/ijms231911416.
10
Role of Nrf2, STAT3, and Src as Molecular Targets for Cancer Chemoprevention.Nrf2、STAT3和Src作为癌症化学预防分子靶点的作用。
Pharmaceutics. 2022 Aug 25;14(9):1775. doi: 10.3390/pharmaceutics14091775.